Abstract
We found a relevant spatial overlap in glioblastomas between hotspots of APTw and FET both in contrast-enhancing and FLAIR-hyperintense tumor. As suggested by earlier studies, APTw was lower in lower-grade gliomas compared with glioblastomas. APTw meaningfully contributes to biological imaging of gliomas.
Introduction: Mapping the Invisible
Gliomas are characterized by significant biological heterogeneity, where the internal makeup of a tumor varies spatially. Standard MRI techniques, such as T1-weighted contrast enhancement, primarily identify blood-brain barrier disruption but often fail to pinpoint areas of high cellular density or aggressive neoangiogenesis. This study evaluates the spatial relationship between three advanced imaging modalities—amino acid PET, Amide Proton Transfer-weighted (APTw) MRI, and perfusion MRI—to better decipher glioma biology.
Addressing Tumor Heterogeneity
The research focuses on how different imaging "maps" reflect the underlying tumor environment. While FET-PET (tracking amino acid uptake) and DSC-perfusion (measuring cerebral blood volume, CBV) are established, APTw imaging is a newer molecular MRI technique. APTw detects the concentration of endogenous proteins and peptides, serving as a proxy for cell density. The study aims to determine if these modalities provide redundant or complementary information by comparing them against stereotactic tissue biopsies.
Methodology: A Multi-Modal Approach
The study analyzed 46 patients (31 with glioblastoma and 15 with lower-grade gliomas). The imaging protocol included:
- FET-PET: Measures metabolic activity via amino acid transport.
- APTw-MRI: Reflects protein concentrations and cellularity.
- DSC-MRI (CBV): Maps new blood vessel growth (neoangiogenesis).
Tumors were segmented into contrast-enhancing (CET) and FLAIR-hyperintense (FHT) regions. "Hotspots" were defined using established thresholds, and spatial overlap was quantified using Dice scores. Findings were validated using 34 targeted biopsies from 10 glioblastoma patients, scored for cellularity and vascularization by a neuropathologist.
Key Insights: Cellularity and Vascularity
The results confirmed that the APTw signal significantly correlates with cell density (Spearman’s rho = 0.37), aligning with the biological expectation that higher protein concentrations reflect higher cellularity.
In glioblastomas, a high spatial overlap was observed between APTw and FET-PET hotspots, particularly in the contrast-enhancing regions. This suggests that both modalities identify similar aggressive biological processes. Conversely, CBV remained the superior marker for vascularity, showing less overlap with APTw, which indicates that cellular density and blood vessel formation are distinct biological features captured by different sequences.
Spatial Overlap and Clinical Implications
Quantitative analysis revealed that APTw hotspots were typically the largest in glioblastomas, followed by PET and then CBV. The spatial agreement (Dice score) was highest between APTw and FET across all tumor regions. Furthermore, APTw values were significantly lower in lower-grade gliomas (LGG) compared to glioblastomas (GBM), supporting its utility in non-invasive tumor grading.
Limitations and Future Directions
While promising, the study noted limitations such as non-simultaneous scan acquisition (4–5 days apart) and a relatively small biopsy-validated subgroup. Future research should involve larger cohorts and explore machine learning integration to improve the prediction of tumor progression and differentiation from treatment effects like radiation necrosis.
Conclusion
APTw imaging provides a valuable, non-invasive measure of tumor cellularity that complements metabolic and perfusion data. Its high spatial overlap with FET-PET in aggressive tumor regions positions it as a key component of multi-modal biological imaging for gliomas.
Summary updated